Article

New OCT parameters associated with wet AMD risk

Although optical coherence tomography is widely used in the diagnosis and management of age-related macular degeneration, closer scrutiny of these scans may reveal useful new parameters, according to Florian M. Heussen, MD.

Fort Lauderdale, FL-Although optical coherence tomography (OCT) is widely used in the diagnosis and management of age-related macular degeneration (AMD), closer scrutiny of these scans may reveal useful new parameters, according to Florian M. Heussen, MD.

In a retrospective review of spectral-domain OCT scans of eyes that had progressed to neovascular AMD and a control group of eyes with high-risk AMD that had not transitioned, two features were strongly associated with imminent development of choroidal neovascularization: hyperreflective foci and pigment epithelial detachments (PED) with heterogeneous internal reflectivity, said Dr. Heussen, Doheny Eye Institute, Keck School of Medicine at the University of Southern California, Los Angeles.

Scans of eyes in both the transition and control groups were randomly assigned and independently graded by two certified graders looking at parameters, such as the presence of a break in the retinal pigment epithelial (RPE) band, thickening or thinning of the RPE band, RPE band integrity, internal reflectivity of the PED (homogenous hyper or hypo or heterogeneous), retinal atrophy, epiretinal membrane, or simplified quantification of any subretinal fluid, cystoid macular edema, or intraretinal hyperreflective foci.

Only hyperreflective foci and heterogeneous PED stood out on univariate analysis, a finding that remained in the multivariate analysis, Dr. Heussen said.

Because this was a small study involving only 20 eyes each in the transitional and control groups, a large prospective study is warranted, he added.

However, until such a study can occur, he recommended closer monitoring of patients whose OCT scans show the two factors associated with transition.

For more articles in this issue of Ophthalmology Times Conference Briefclick here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.